Core Viewpoint - The announcement by Huajian Medical Holdings Limited regarding its partnership with ETHK Group marks a significant step towards creating a new financial ecosystem on the blockchain, aiming to enhance the global flow and reconstruction of value in the healthcare sector [1][5]. Group 1: Company Strategy and Transformation - Huajian Medical has changed its name to Huajian Digital Industry Group Limited, reflecting its strategic shift towards digital finance and blockchain technology [1][4]. - The collaboration with ETHK Group aims to establish two new companies, ETHK INC and ETHK HOLDINGS LIMITED, focusing on decentralized financial platforms and global capital integration [1][6]. - The partnership is seen as a strategic extension of Huajian Medical's efforts to explore a dual-driven model of "assets + finance," enhancing the liquidity and global accessibility of its innovative assets [9][11]. Group 2: ETHK Ecosystem Development - The ETHK ecosystem is built on five key pillars: technological infrastructure, financial products and asset matrix, sustainable business models, global compliance frameworks, and seamless user experience [7][8]. - The focus on asset tokenization, particularly in the healthcare sector, aims to facilitate efficient global financing and value discovery for high-quality Chinese assets [8][12]. - The initiative is positioned as a response to the growing trend of Real World Asset (RWA) tokenization, which is gaining traction among major financial institutions globally [12][14]. Group 3: Market Implications and Future Outlook - The collaboration is expected to redefine the global financial landscape by breaking down barriers for Chinese assets and enabling them to engage in a global value dialogue [13][14]. - The project is viewed as a significant opportunity for Chinese enterprises to align with global regulatory frameworks while innovating within the blockchain space [15]. - The success of this initiative could position Huajian Medical as a key player in the emerging digital financial ecosystem, potentially reshaping the global financial order [16][17].

Core Viewpoint - Huajian Medical (01931) is undergoing a strategic transformation to become a digital industry technology innovator, marking a shift from a traditional medical enterprise to a focus on blockchain and decentralized finance through the establishment of new companies and a name change [1][3][4]. Group 1: Strategic Transformation - Huajian Medical has announced a partnership with ETHK Group to jointly invest in two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, aimed at developing a decentralized financial platform and a digital industry investment hub [4][6]. - The company will change its name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "Huajian Digital Industry Group Limited," reflecting its ambition to become a core technology driver in the global digital industry [3][6]. Group 2: ETHK Ecosystem - The "ETHK" brand name combines "ETH" (Ether) and "K" (Kingdom), symbolizing a vision for a decentralized financial ecosystem that aligns with blockchain technology [7]. - ETHK Labs will focus on advanced technology research and development, serving as the technological foundation and innovation engine for the ETHK ecosystem [7]. Group 3: RWA Market Opportunity - The transformation aligns with the explosive growth of the Real World Asset (RWA) market, which saw a total locked value (TVL) increase from $8.6 billion to over $23 billion in the first half of 2025, a growth of over 260% [8][9]. - Predictions indicate that the global RWA market could reach $16.1 trillion by 2030, representing 10% of global GDP, positioning Huajian Medical to lead in RWA infrastructure development [9]. Group 4: Value Reconstruction - The strategic upgrade aims to enhance China's global digital financial influence by facilitating the "on-chain" transition of quality Chinese assets [10]. - The ETHK ecosystem is expected to address financing challenges for enterprises and promote global asset integration, contributing to financial inclusivity and stability [10]. - The company's valuation model is shifting from traditional earnings-based metrics to revenue-based metrics, reflecting its new focus on digital infrastructure [10].

Core Viewpoint - Huajian Medical (01931) has announced a strategic upgrade, including the establishment of two joint ventures with ETHK Group and a name change to reflect its transformation into a digital industry innovator [1][4][5]. Group 1: Strategic Transformation - The company has formed joint ventures, ETHK Inc and ETHK HOLDINGS LIMITED, to enhance its global blockchain financial ecosystem [5]. - ETHK Inc will focus on developing a decentralized financial platform under the "ETHK" brand, while ETHK HOLDINGS LIMITED will serve as a digital industry investment and acquisition hub [5]. - The company will change its name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [4][5]. Group 2: Blockchain Financial Ecosystem - The "ETHK" brand name combines "Ether" and "Kingdom," symbolizing a decentralized financial ecosystem that aligns with blockchain technology [9]. - ETHK Labs will be the core institution for advanced technology research and ecosystem empowerment within the ETHK framework [9]. - The company aims to redefine global asset circulation and value exchange through a next-generation blockchain financial ecosystem [9]. Group 3: RWA Market Opportunity - The transformation aligns with the explosive growth of the Real World Asset (RWA) market, which saw a total locked value (TVL) of $12.5 billion as of June 2025, a 124% increase from 2024 [10]. - The RWA market surged from $8.6 billion to over $23 billion in the first half of 2025, marking a growth of over 260% [11]. - By establishing joint ventures and rebranding, the company positions itself to lead the global RWA infrastructure development [11]. Group 4: Value Reconstruction - The strategic upgrade aims to enhance China's global digital financial influence by facilitating the "on-chain" movement of quality Chinese assets [12]. - The blockchain financial model promotes transparency and efficiency, addressing financing challenges for enterprises and supporting global asset integration [13]. - The transformation signifies a shift in valuation logic from traditional earnings-based models to revenue-based models, reflecting the company's new focus on digital infrastructure [13].

公告称，为更准确地体现集团作为"ETHK"链上金融生态体系关键技术与基础设施提供者的全新定位， 董事会认为，更改公司名称符合公司及股东的整体最佳利益。新名称"ETHK Labs Inc./华检数字产业集 团有限公司"将更能代表集团致力于成为全球数字产业创新与链上金融核心技术驱动者的宏伟抱负。 智通财经APP讯，华检医疗(01931)公布，董事会建议将公司的英文名称由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，并将公司的中文双重外文名称由"华检医疗控股有限公司"更改为"华 检数字产业集团有限公司"。 ...

Core Viewpoint - The company has entered into a partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, which will be incorporated into the company's consolidated financial statements [1][2]. Group 1: Company Overview - ETHK Group is an investment holding group focused on the global blockchain financial ecosystem, aiming to build the next-generation blockchain financial kingdom named "ETHK" [1]. - ETHK Inc will focus on operating and developing the "ETHK" core brand, aiming to create a secure, efficient, compliant, and open decentralized financial platform [1]. - ETHK HOLDINGS LIMITED will serve as a central hub for digital industry investment and mergers, focusing on asset completion, capital activation, and compliance strengthening [2]. Group 2: Strategic Goals - The partnership aligns with the group's strategy to build a Real World Asset (RWA) platform technology ecosystem and explore blockchain finance [3]. - The initiative aims to expand from focusing on RWA transactions to a comprehensive blockchain financial ecosystem that includes technology infrastructure, asset categories, business models, and global compliance [3]. - The group aims to participate in and lead the process of "on-chain" integration of quality Chinese assets and efficient global asset circulation, creating a new long-term growth trajectory [3].

Core Viewpoint - Guofu Quantum Innovation Co., Ltd. is strategically positioning itself in the RWA (Real World Asset) market by launching the RWA8 Fund, aiming to enhance its competitiveness in the RWA and on-chain finance sectors while contributing to Hong Kong's economic digital transformation [1][5][7] Group 1: Fund and Market Positioning - The RWA8 Fund is a key component of Guofu Quantum's Pre-RWA strategic layout, focusing on preemptive investments in tokenizable quality underlying assets such as equity, income rights, bonds, and artworks [3] - The RWA market is projected to exceed trillions of dollars by 2030, attracting intense competition among global financial institutions [3] - Guofu Quantum holds significant licenses and qualifications, enabling it to provide comprehensive support for the tokenization and on-chain circulation of underlying assets, thereby solidifying its competitive position [3] Group 2: Business Model and Ecosystem Development - Guofu Quantum aims to create a comprehensive ecosystem encompassing exchanges, RWA investment banks, Pre-RWA funds, RWA secondary market funds, and fintech, marking a significant enhancement of its RWA value chain [4] - The company is transitioning from a traditional investment entity to an RWA ecosystem operator and service provider, diversifying its revenue streams to include management fees, underwriting fees, and transaction fees [4] Group 3: Strategic Goals and Industry Impact - The establishment of the RWA8 Fund is not merely a fund investment but a strategic move to become a foundational builder of Hong Kong's economic digital transformation [5][6] - Guofu Quantum's strategy aligns with the Hong Kong government's vision of developing eight key centers, aiming to digitize and tokenize assets related to these centers [5] - The company's approach represents a significant shift in traditional finance, positioning it as a bridge between cryptocurrency and the real economy, with the potential to reshape Hong Kong's digital economy landscape [7]

Core Viewpoint - Guofu Quantum (00290) has seen a significant increase in stock price, with a year-to-date rise of nearly 180%, currently trading at 2.19 HKD with a transaction volume of 23.88 million HKD. The company announced a major share sale that will result in a new single largest shareholder, enhancing its strategic collaboration in the digital finance sector [1]. Group 1: Shareholder Changes - Guofu Quantum's largest shareholder, Liu Zhiwei, along with shareholder Wang Tao, will sell a total of 1.848 billion shares to FINAL TOUCH LTD., a wholly-owned subsidiary of Huajian Medical, for 3.142 billion HKD, representing approximately 20.31% of the company's issued share capital [1]. - Following the completion of this transaction, Huajian Medical will become the single largest shareholder of Guofu Quantum [1]. Group 2: Strategic Collaboration - The two companies will focus on building a comprehensive strategic collaboration around "on-chain finance," aiming to innovate and implement digital financial infrastructure [1]. - They plan to integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for on-chain asset issuance, trading, and management, accelerating the digitization, fragmentation, and cross-border flow of traditional financial assets [1]. Group 3: Recent Collaborations - On August 31, Guofu Quantum entered into a cooperation agreement with Meinian Health (002044) and Jingbeifang (002987) to explore digital rights and RWA tokenization using the revenue rights of Meinian Health's equipment assets, data assets, AI, and other emerging technology digital assets as underlying assets [1]. - This collaboration aims to explore new paradigms for releasing the value of equipment and data assets in the health care sector, contributing to the upgrade and innovative development of the health industry [1].

Group 1 - The transaction involves a share transfer of approximately HKD 31.42 billion, marking a significant shift in the ownership structure of two Hong Kong-listed companies, Guofu Quantum Innovation Co., Ltd. and Huajian Medical Holdings Limited [1][2] - Huajian Medical will acquire 20.31% of Guofu Quantum's shares, becoming its largest shareholder, while the previous major shareholder, Liu Zhiwei, will retain influence through his stake in Huajian Medical [1][3] - The acquisition is part of Huajian Medical's strategy to advance its Real World Asset (RWA) exchange initiative, integrating Guofu Quantum into its ecosystem [1][5] Group 2 - The payment method for the acquisition is through the issuance of new shares rather than cash, preserving Huajian Medical's financial strength while allowing the sellers to benefit from future value appreciation [2][3] - The share price of HKD 9.69 represents an 11.8% premium over the average closing price prior to the agreement, reflecting confidence in the company's valuation [2][3] Group 3 - Liu Zhiwei has been a pivotal figure in Hong Kong's fintech sector, transforming Guofu Quantum into a platform focused on fintech, quantum computing, and blockchain [4] - His strategic vision includes the establishment of the "Hong Kong Digital Asset Listed Companies Alliance" and a comprehensive RWA development strategy, indicating a deep understanding of the digital asset ecosystem [4][5] Group 4 - The collaboration between Huajian Medical and Guofu Quantum aims to create a closed-loop ecosystem for RWA, leveraging Guofu Quantum's financial licenses and technological expertise to enhance Huajian Medical's RWA operations [5][6] - The partnership is aligned with Hong Kong's governmental push for virtual asset development and financial technology innovation, positioning both companies to capitalize on emerging market opportunities [7][10] Group 5 - The transaction may lead to a dilution of Huajian Medical's existing shareholders' equity by approximately 16.7%, raising potential concerns among investors [9] - Effective integration of the two companies, which have differing focuses—healthcare for Huajian Medical and fintech for Guofu Quantum—will be crucial for realizing synergies [9][10] Group 6 - The RWA sector is poised for significant growth, with the potential to enhance liquidity and attract global investors through the tokenization of traditional assets [7][10] - The partnership is expected to facilitate the internationalization of Chinese assets, aligning with broader trends in global finance and digital innovation [11][12]

Group 1 - The core point of the article is that Guofu Quantum (00290) has resumed trading with its stock price surging over 8% following the announcement of a significant share sale [1] - Guofu Quantum's largest shareholder, Liu Zhiwei, and shareholder Wang Tao will sell a total of 1.848 billion shares, representing approximately 20.31% of the company's issued share capital, to FINAL TOUCH LTD., a wholly-owned subsidiary of Huajian Medical, for HKD 3.142 billion [1] - After the transaction, Liu Zhiwei will no longer be the largest shareholder, and the buyer will become the new largest shareholder [1] Group 2 - Huajian Medical announced plans to collaborate with Guofu Quantum to build a comprehensive strategic synergy around "on-chain finance," focusing on the innovation and implementation of digital financial infrastructure [1] - The two companies will integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for the issuance, trading, and management of on-chain assets, aiming to accelerate the digitization, fragmentation, and cross-border flow of traditional financial assets [1]

智通财经APP获悉，国富量子(00290)午后复牌，股价飙升逾8%。截至发稿，涨7.98%，报2.03港元，成 交额2435.89万港元。 华检医疗公告表示，展望未来，华检医疗将与国富量子围绕"链上金融"生态构建全面深化战略协同，共 同推动数字金融基础设施的创新与落地。双方将整合技术、牌照、资产与渠道资源，着力打造高效、合 规、开放的链上资产发行、交易及管理平台，加速实现传统金融资产的数字化、碎片化与跨境流动。 消息面上，国富量子公告，公司单一最大股东柳志伟及股东王涛将向华检医疗的全资附属公司FINAL TOUCH LTD.出售合共18.48亿股公司股份，占公司已发行股本约20.31%，代价为31.42亿港元。交易完 成后，柳志伟将不再是单一最大股东，而买方将成为公司的单一最大股东。国富量子董事会预计此变动 不会对公司日常营运产生重大不利影响。 ...